Skip to content
Recall Observatory FDA recall evidence

Drug product

Lorazepam Injection, USP, 2mg/mL, 1 mL vial, 25 vials per carton, RX Only, Manufactured by West-Ward Eatontown, NJ 07724, Carton NDC# 0641-6044-25, Vial NDC# 0641-6044-01

D-1307-2022

July 11, 2022

Class II

Product summary

Firm
Hikma Pharmaceuticals USA Inc.
Event
Event 90583
Status
Terminated
Classification
Class II
Quantity
4,739,000 vials
Official record key
drug-enforcement:D-1307-2022

Official wording

Reason: Failed Impurities/Degradation Specifications: Out-of-specification results observed for total related compounds during testing of retain samples.

Code information: Lot # 060064, Exp. 06/2023, 070084, Exp. 07/2023, 070126, Exp. 07/2023, 080091, Exp. 08/2023, 080060, Exp. 08/2023

Distribution pattern: Nationwide in the USA

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Out-of-specification